| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $75.25M | $55.19M | $62.64M | $27.16M | – |
| R&D | $42.08M | $24.40M | $44.00M | $23.69M | – |
| SG&A | $33.16M | $30.79M | $18.64M | $2.29M | $720.70K |
| Operating Income | -$75.25M | -$55.19M | -$62.64M | -$2.68M | -$888.54K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | $0.00 | $0.00 | – | – |
| Net Income | -$68.65M | -$52.40M | -$60.36M | $3.55M | $6.85M |
| EPS (basic) | -1.0600 | -0.6000 | -2.0900 | -141.9700 | – |
| EPS (diluted) | -1.0600 | -0.6000 | -2.0900 | -141.9700 | – |
| Shares (diluted) | $94.16M | $75.07M | $33.06M | $228.15K | – |